ORIGINAL RESEARCH article

Front. Oncol.

Sec. Breast Cancer

Volume 15 - 2025 | doi: 10.3389/fonc.2025.1586715

This article is part of the Research TopicAI-Powered Insights: Predicting Treatment Response and Prognosis in Breast CancerView all articles

Comparative Analysis of Multi-zone Peritumoral Radiomics in Breast Cancer for Predicting NAC Response Using ABVS-based Deep Learning Models

Provisionally accepted
Minfang  WangMinfang Wang1*Wanjun  ChenWanjun Chen1Ruiping  RenRuiping Ren1Yuanwei  LinYuanwei Lin2Jiawen  TangJiawen Tang1Meng  WuMeng Wu1*
  • 1The Affiliated People's Hospital of Ningbo University, Ningbo, China
  • 2The First Affiliated Hospital of Ningbo University, Ningbo, China

The final, formatted version of the article will be published soon.

Background: Peritumoral characteristics demonstrate significant predictive value for neoadjuvant chemotherapy (NAC) response in breast cancer (BC) through tumor-stromal interactions. Radiomics analysis of peritumoral regions has shown robust capability in predicting treatment outcomes; however, the optimal peritumoral thickness for maximizing predictive accuracy remains undefined.Objective: To establish a clinically implementable framework for early identification of NAC non-responders through standardized prediction modeling. This study aims to determine the optimal peritumoral thickness for NAC response prediction by training and systematically comparing artificial intelligence (AI)-driven radiomics models across multiple peritumoral zones using Automated Breast Volume Scanning (ABVS).Methods: A total of 402 BC patients who received NAC were retrospectively analyzed. Pre-treatment ABVS images were processed to extract radiomic features from five regions of interest (ROIs): the intratumoral region (R0) and four consecutive peritumoral zones (R2-R8) extending outward at 2-mm intervals. The study cohort was divided into training and testing cohorts. ROI-specific TabNet models were developed using the training cohort data. Comparative analysis was performed in the testing cohort through comprehensive performance evaluation, including discrimination, calibration, clinical utility assessment, and classification metrics, to identify the optimal peritumoral zone. The radiomics features of the best-performing model were ranked by importance, with subsequent ablation studies validating the predictive contribution of high-ranking features.Results: Among the study population, 138 patients (34.3%) were classified as NAC non-responders. Model evaluation demonstrated progressively improved predictive performance from R0 to R6, with area under the ROC curves increasing from 0.681 to 0.845. The R6 model demonstrated optimal performance with accuracy of 0.810 and precision of 0.765. The combined model integrating R0 and R6 features enhanced predictive capability, achieving accuracy of 0.909, precision of 0.841, and recall of 0.902. Feature importance analysis identified textural heterogeneity and volumetric characteristics as the most influential variables, with the top features derived predominantly from the 6-mm peritumoral region.Conclusion: The 6-mm peritumoral zone demonstrated optimal predictive value for NAC response, with the AI-driven combined intratumoral-peritumoral model achieving superior performance. This standardized ABVS-based radiomics approach enables early identification of potential NAC non-responders, facilitating timely therapeutic modifications.

Keywords: breast cancer, Neoadjuvant chemotherapy, Radiomics, Automated breast volume scanning, Peritumoral features, artificial intelligence

Received: 03 Mar 2025; Accepted: 28 Apr 2025.

Copyright: © 2025 Wang, Chen, Ren, Lin, Tang and Wu. This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY). The use, distribution or reproduction in other forums is permitted, provided the original author(s) or licensor are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms.

* Correspondence:
Minfang Wang, The Affiliated People's Hospital of Ningbo University, Ningbo, China
Meng Wu, The Affiliated People's Hospital of Ningbo University, Ningbo, China

Disclaimer: All claims expressed in this article are solely those of the authors and do not necessarily represent those of their affiliated organizations, or those of the publisher, the editors and the reviewers. Any product that may be evaluated in this article or claim that may be made by its manufacturer is not guaranteed or endorsed by the publisher.